Mesna compared with continuous bladder irrigation as uroprotection during high-dose chemotherapy and transplantation: a randomized trial

J Clin Oncol. 1993 Jul;11(7):1306-10. doi: 10.1200/JCO.1993.11.7.1306.

Abstract

Purpose: To compare the use of intravenous (IV) hydration plus either continuous bladder irrigation or mesna for the prevention of hemorrhagic cystitis in the bone marrow transplant setting.

Patients and methods: Two hundred patients were prospectively randomized to receive either continuous bladder irrigation with 200 mL/h of normal saline, or continuous infusion mesna at 100% of the cyclophosphamide dose.

Results: The overall incidence of hematuria of any grade was significantly higher in the bladder-irrigation group (76%) compared with the mesna group (53%) (P = .007). However, the incidence of grade III and IV hematuria was the same in both groups (18%; P = NS). Moderate or severe discomfort or bladder spasms were reported in 84% of the patients who received bladder irrigation, compared with 2% of the patients who received mesna prophylaxis (P < .0001). Urinary tract infections (UTIs) were documented in 27% of the patients in the bladder-irrigation group, compared with 14% of the patients in the mesna group (P = .03).

Conclusion: Both continuous bladder irrigation and mesna were equally effective in preventing severe hemorrhagic cystitis associated with high-dose cyclophosphamide and bone marrow transplantation. However, the use of mesna was associated with significantly less discomfort and a lower incidence of UTIs.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Bone Marrow Transplantation / adverse effects*
  • Combined Modality Therapy
  • Cyclophosphamide / adverse effects
  • Cystitis / etiology
  • Cystitis / prevention & control*
  • Female
  • Hematuria / etiology
  • Hematuria / prevention & control*
  • Humans
  • Male
  • Mesna / therapeutic use*
  • Middle Aged
  • Neoplasms / therapy
  • Prospective Studies
  • Therapeutic Irrigation / methods
  • Urinary Bladder

Substances

  • Cyclophosphamide
  • Mesna